NASDAQ:WVE - Wave Life Sciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$38.20 -2.27 (-5.61 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$40.47
Today's Range$38.15 - $41.95
52-Week Range$15.15 - $55.95
Volume829,100 shs
Average Volume179,511 shs
Market Capitalization$1.47 billion
P/E Ratio-10.21
Dividend YieldN/A
Wave Life Sciences logoWave Life Sciences Ltd., a biotechnology company, designs, develops, and commercializes nucleic acid therapeutic candidates for genetically defined diseases by utilizing proprietary synthetic chemistry drug development platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics, as well as a collaboration agreement with Deep Genomics Inc. for identifying novel therapies. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations


Debt-to-Equity Ratio0.04
Current Ratio7.24
Quick Ratio7.24


Trailing P/E Ratio-10.21
Forward P/E Ratio-7.99
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.70 million
Price / Sales300.44
Cash FlowN/A
Price / CashN/A
Book Value$5.03 per share
Price / Book7.59


EPS (Most Recent Fiscal Year)($3.85)
Net Income$-102,030,000.00
Net Margins-2,613.03%
Return on Equity-76.93%
Return on Assets-61.14%


Outstanding Shares29,100,000

Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd (NASDAQ:WVE) released its quarterly earnings results on Wednesday, May, 9th. The company reported ($1.26) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.90) by $0.36. The business earned $1.42 million during the quarter, compared to analyst estimates of $6.59 million. Wave Life Sciences had a negative net margin of 2,613.03% and a negative return on equity of 76.93%. View Wave Life Sciences' Earnings History.

When is Wave Life Sciences' next earnings date?

Wave Life Sciences is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Wave Life Sciences.

What price target have analysts set for WVE?

4 equities research analysts have issued twelve-month price targets for Wave Life Sciences' stock. Their forecasts range from $40.00 to $65.00. On average, they anticipate Wave Life Sciences' stock price to reach $56.75 in the next twelve months. View Analyst Ratings for Wave Life Sciences.

Who are some of Wave Life Sciences' key competitors?

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the folowing people:
  • Dr. Paul B. Bolno, Pres, CEO & Director (Age 44)
  • Mr. Keith Regnante, Chief Financial Officer (Age 48)
  • Dr. Michael A. Panzara, Franchise Lead of Neurology (Age 51)
  • Dr. Takeshi Wada, Scientific Advisor (Age 56)
  • Mr. Kyle B. Moran, Sr. VP of Supply Chain & Operations (Age 47)

Has Wave Life Sciences been receiving favorable news coverage?

Headlines about WVE stock have been trending somewhat positive this week, according to Accern. Accern identifies negative and positive press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Wave Life Sciences earned a news impact score of 0.07 on Accern's scale. They also assigned media coverage about the company an impact score of 46.90 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are Wave Life Sciences' major shareholders?

Wave Life Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional investors include KAGOSHIMA SHINSANGYO SOUSEI INVESTMENT LIMITED PARTNERSHIP (8.90%), KAGOSHIMA SHINSANGYO SOUSEI INVESTMENT LIMITED PARTNERSHIP (8.90%), Redmile Group LLC (7.69%), BB Biotech AG (3.08%), BlackRock Inc. (3.01%) and Eventide Asset Management LLC (1.30%). Company insiders that own Wave Life Sciences stock include Chandra Vargeese, Chris Francis, Keith Regnante, Masaharu Tanaka, Michael A Panzara, Paul Bolno and Ra Capital Management, Llc. View Institutional Ownership Trends for Wave Life Sciences.

Which major investors are selling Wave Life Sciences stock?

WVE stock was sold by a variety of institutional investors in the last quarter, including Foresite Capital Management III LLC, BlackRock Inc., Point72 Asset Management L.P., Eventide Asset Management LLC, Bailard Inc., Schwab Charles Investment Management Inc., JPMorgan Chase & Co. and A.R.T. Advisors LLC. Company insiders that have sold Wave Life Sciences company stock in the last year include Chandra Vargeese, Chris Francis, Keith Regnante, Masaharu Tanaka, Michael A Panzara and Paul Bolno. View Insider Buying and Selling for Wave Life Sciences.

Which major investors are buying Wave Life Sciences stock?

WVE stock was bought by a variety of institutional investors in the last quarter, including Spark Investment Management LLC, Artal Group S.A., DAFNA Capital Management LLC, BB Biotech AG, Platinum Investment Management Ltd., Redmile Group LLC, Citadel Advisors LLC and GSA Capital Partners LLP. View Insider Buying and Selling for Wave Life Sciences.

How do I buy shares of Wave Life Sciences?

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of WVE stock can currently be purchased for approximately $38.20.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $1.47 billion and generates $3.70 million in revenue each year. The company earns $-102,030,000.00 in net income (profit) each year or ($3.85) on an earnings per share basis. Wave Life Sciences employs 168 workers across the globe.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]

MarketBeat Community Rating for Wave Life Sciences (WVE)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  167 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  295
MarketBeat's community ratings are surveys of what our community members think about Wave Life Sciences and other stocks. Vote "Outperform" if you believe WVE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WVE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.